MAP3K5 and cancer: Cancer and inflammatory, cardiovascular, and neurodegenerative diseases, among others, have been extensively associated with excessive ASK1 signaling, in particular (Katome et al., 2013; Ma et al., 2019; Meijles et al., 2020; Okazaki, 2017).